Log in or Sign up for Free to view tailored content for your specialty!
Neuro-Oncology News
Undiagnosed depression common among patients with cancer
Forty percent of adults at an urban cancer center received a diagnosis of depression, according to a study presented at the American Society for Radiation Oncology Annual Meeting.
Medicaid expansion cuts uninsured rate by half among patients with cancer
States that enacted Medicaid expansion as part of the Patient Protection and Affordable Care Act showed a reduction in uninsured rates among patients with cancer receiving radiation, according to a study presented at the American Society for Radiation Oncology Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Baseball Hall of Famer: Physician’s confidence affects patients
Mike Schmidt, whose success during his 17-year career with the Philadelphia Phillies earned him induction into the National Baseball Hall of Fame, received a stage III melanoma diagnosis 4 years ago.
Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis
Mike Schmidt, elected to the National Baseball Hall of Fame in 1995, developed a sense of invincibility during his 17-year career with the Philadelphia Phillies.
One-quarter of patients with cancer report legal marijuana use
One-quarter of patients with cancer in a state with legalized marijuana reported using the substance in the prior year, according to results of a cross-sectional, anonymous survey published in Cancer.
Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use
Mike Schmidt, a former member of the Philadelphia Phillies widely considered to be the greatest third baseman in Major League Baseball history, received a stage III melanoma diagnosis in 2013.
Mike Schmidt, baseball great and melanoma survivor, promotes importance of ‘cancer game plan’
Mike Schmidt is widely considered the greatest third baseman in Major League Baseball history.
Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer
Mike Schmidt always felt a sense of invincibility as a professional athlete.
FDA approves Mvasi, first biosimilar for cancer
The FDA today approved the first biosimilar for cancer — bevacizumab-awwb — to treat patients with multiple types of cancer.
AACR: Breakthroughs in cancer research require ‘strong federal commitment’
Basic research in immunotherapy and precision medicine remains at the forefront of progress in cancer treatment; however, a strong bipartisan commitment from Congress is needed to continue this progress, according to the seventh annual AACR Cancer Progress Report.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read